Foojan Zeine

Dr. Foojan Zeine

Health & Science, California State University, Long Beach, Long Beach, California, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Psychology Research and Behavior Management
Verified
Journal Article
Open access
PDF file
ABAbdalla Bowirrat
Abdalla Bowirrat
Igor ElmanIgor Elman
Igor Elman
CDCatherine A Dennen
Catherine A Dennen
MGMarjorie C Gondré-Lewis
Marjorie C Gondré-Lewis
JCJean Lud Cadet
Jean Lud Cadet
KBKenneth Blum
Kenneth Blum
Loneliness, an established risk factor for both, mental and physical morbidity, is a mounting public health concern. However, the neurobiological mechanisms underlying loneliness-related morbidity are not yet well defined. Here we examined the role of genes and associated DNA risk polymorphic variants that are implicated in loneliness via genetic and epigenetic mechanisms and may thus point to specific therapeutic targets. Searches were conducted on PubMed, Medline, and EMBASE databases using specific Medical Subject Headings terms such as loneliness and genes, neuro- and epigenetics, addiction, affective disorders, alcohol, anti-reward, anxiety, depression, dopamine, cancer, cardiovascular, cognitive, hypodopaminergia, medical, motivation, (neuro)psychopathology, social isolation, and reward deficiency. The narrative literature review yielded recursive collections of scientific and clinical evidence, which were subsequently condensed and summarized in the following key areas: (1) Genetic Antecedents: Exploration of multiple genes mediating reward, stress, immunity and other important vital functions; (2) Genes and Mental Health: Examination of genes linked to personality traits and mental illnesses providing insights into the intricate network of interaction converging on the experience of loneliness; (3) Epigenetic Effects: Inquiry into instances of loneliness and social isolation that are driven by epigenetic methylations associated with negative childhood experiences; and (4) Neural Correlates: Analysis of loneliness-related affective states and cognitions with a focus on hypodopaminergic reward deficiency arising in the context of early life stress, eg, maternal separation, underscoring the importance of parental support early in life. Identification of the individual contributions by various (epi)genetic factors presents opportunities for the creation of innovative preventive, diagnostic, and therapeutic approaches for individuals who cope with persistent feelings of loneliness. The clinical facets and therapeutic prospects associated with the current understanding of loneliness, are discussed emphasizing the relevance of genes and DNA risk polymorphic variants in the context of loneliness-related morbidity.

27 March 2024 in Health Sciences Review
Verified
Journal Article
Open access
Foojan ZeineFoojan Zeine
Foojan Zeine
NJNicole Jafari
Nicole Jafari
MNMohammad Nami
Mohammad Nami
KBKenneth Blum
Kenneth Blum

Verified
Journal Article
Open access
PDF file
Kai-Uwe LewandrowskiKai-Uwe Lewandrowski
Kai-Uwe Lewandrowski
KBKenneth Blum
Kenneth Blum
Alireza SharafshahAlireza Sharafshah
Alireza Sharafshah
KTKyriaki Z. Thanos
Kyriaki Z. Thanos
Panayotis ThanosPanayotis Thanos
Panayotis Thanos
SSSergio Luis Schmidt
Sergio Luis Schmidt
Background: In the United States, approximately 1 in 5 children experience comorbidities with mental illness, including depression and anxiety, which lead to poor general health outcomes. Adolescents with substance use disorders exhibit high rates of co-occurring mental illness, with over 60% meeting diagnostic criteria for another psychiatric condition in community-based treatment programs. Comorbidities are influenced by both genetic (DNA antecedents) and environmental (epigenetic) factors. Given the significant impact of psychiatric comorbidities on individuals’ lives, this study aims to uncover common mechanisms through a Genome-Wide Association Study (GWAS) meta-meta-analysis. Methods: GWAS datasets were obtained for each comorbid phenotype, followed by a GWAS meta-meta-analysis using a significance threshold of p < 5E−8 to validate the rationale behind combining all GWAS phenotypes. The combined and refined dataset was subjected to bioinformatic analyses, including Protein–Protein Interactions and Systems Biology. Pharmacogenomics (PGx) annotations for all potential genes with at least one PGx were tested, and the genes identified were combined with the Genetic Addiction Risk Severity (GARS) test, which included 10 genes and eleven Single Nucleotide Polymorphisms (SNPs). The STRING-MODEL was employed to discover novel networks and Protein–Drug interactions. Results: Autism Spectrum Disorder (ASD) was identified as the top manifestation derived from the known comorbid interaction of anxiety, depression, and attention deficit hyperactivity disorder (ADHD). The STRING-MODEL and Protein–Drug interaction analysis revealed a novel network associated with these psychiatric comorbidities. The findings suggest that these interactions are linked to the need to induce “dopamine homeostasis” as a therapeutic outcome. Conclusions: This study provides a reliable genetic and epigenetic map that could assist healthcare professionals in the therapeutic care of patients presenting with multiple psychiatric manifestations, including anxiety, depression, and ADHD. The results highlight the importance of targeting dopamine homeostasis in managing ASD linked to these comorbidities. These insights may guide future pharmacogenomic interventions to improve clinical outcomes in affected individuals.

3 June 2025 in Gene & Protein in Disease
Verified
Journal Article
Open access
PDF file
KBKenneth Blum
Kenneth Blum
EBEric R. Braverman
Eric R. Braverman
Alireza SharafshahAlireza Sharafshah
Alireza Sharafshah
Igor ElmanIgor Elman
Igor Elman
Kai-Uwe LewandrowskiKai-Uwe Lewandrowski
Kai-Uwe Lewandrowski
JKJag Khalsa
Jag Khalsa
Artificially increasing dopamine transmission is the common mechanism by which substances with addictive potential lead to addiction. A key area of research in neurobiology is the role of dopamine. Significant advancements have been made in uncovering the intracellular signaling pathways that mediate both dopamine’s immediate effects and its long-term influence on brain function. Recent discoveries have also highlighted specific molecules that could serve as potential therapeutic targets for neurological and psychiatric disorders. While understanding several important caveats, we believe dopamine acts as a master regulator of brain circuitry across major chromosomes mapping the mental health genome. This view may have important clinical relevance, emphasizing the critical role of dopaminergic activity across the genome. Importantly, we are cognizant that dopamine does not work in insolation, and its finite actions are due to a highly interactive network (known as the brain reward cascade), involving at least seven other major neurotransmitters.

20 June 2024
Verified
Journal Article
Open access
Foojan ZeineFoojan Zeine
Foojan Zeine
NJNicole Jafari
Nicole Jafari
DBDavid Baron
David Baron
ABAbdalla Bowirrat
Abdalla Bowirrat
APAlbert Pinhasov
Albert Pinhasov
KBKenneth Blum
Kenneth Blum
The opioid crisis in the last few decades has mounted to a global level, impacting all areas of socioeconomic, demographic, geographic, and cultural boundaries. Traditional treatments have not been deemed to show the degree of efficacy necessary to address the crisis. The authors of this review paper have set forth an unprecedented and in-depth look into multi-factorial determinants that have contributed to the opioid crisis becoming global and multi-faceted. For this narrative review/opinion article, we searched PsychINFO, PubMed, Google Scholar, and Web of Science databases to identify relevant articles on topics including the “opioid crisis,” “opioid mechanisms,” “genetics and epigenetics,” “neuropharmacology,” and “clinical aspects of opioid treatment and prevention.” Since this was not a systematic review the articles selected could represent unitential bias. Despite some success achieved through Opioid Substitution Therapy (OST) in harm reduction, the annual mortality toll in the US alone surpasses 106,699 individuals, a figure expected to climb to 165,000 by 2025. Data from the Substance Abuse and Mental Health Services Administration’s (SAMHSA) National Survey on Drug Abuse and Health (NSDUH) reveals that approximately 21.4% of individuals in the US engaged in illicit drug use in 2020, with 40.3 million individuals aged 12 or older experiencing a Substance Use Disorder (SUD). Provisional figures from the Centers for Disease Control and Prevention (CDC) indicate a troubling 15% increase in overdose deaths in 2021, rising from 93,655 in 2020 to 107,622, with opioids accounting for roughly 80,816 of these deaths. We advocate reevaluating the “standard of care” and shifting towards inducing dopamine homeostasis by manipulating key neurotransmitter systems within the brain’s reward cascade. We propose a paradigm shift towards a novel “standard of care” that begins with incorporating Genetic Addiction Risk Severity (GARS) testing to assess pre-addiction risk and vulnerability to opioid-induced addiction; emphasis should be placed on inducing dopamine homeostasis through safe and non-addictive alternatives like KB220, and comprehensive treatment approaches that address psychological, spiritual, and societal aspects of addiction through Awareness Integration Therapy (AIT).

1 January 2025 in Medical Research Archives
Verified
Journal Article
Open access
PDF file
Foojan ZeineFoojan Zeine
Foojan Zeine
This perspective paper addresses the multifaceted inner mechanism of self-awareness and self- identity developmental milestones as vital pathways to achieving evolutionary survival techniques, life satisfaction, and optimized psychopathology while discussing the Awareness Integration Theory as a sustainable model to assist individuals in overcoming obstacles to inadequacy in proper self-inventory needed for healthy self-development. In this paper, we espoused why AIT may offer a novel strategic approach when integrated into a self-help program, and these applied concepts and theories of self-identity principles and phases. A vital tenant herein posits that applying self-identity theory and concepts through the lens of AIT is an effective and efficient approach to becoming aware of our various self-identities and consciously generating a flexible, adaptable, and workable identity regardless of what life brings forth. As a dedicated clinical and scientific team to provide putative new clinically relevant targets incorporating AIT principles and embracing AIT's six phases to build self- identity, it fosters an effortless presentation of our identity when we are congruent and aims for integration with integrity. Based on our preliminary pharmacogenomic research and initial findings, we encourage the scientific community to confirm further or refute these Genome- Wide Association Studies (GWAS)-based deep in silico PGx analyses for both self and identity and for personality disorders in general. The article discusses different concepts of self as defined based on philosophical accounts, psychological, and cognitive as well as neuroscientific data on self and self-reference and how these multidisciplinary ideas are complementary. Finally, both philosophical and neuroscientific accounts are directly compared with each other while, at the same time, their relevance for the psychoanalysis of self and ego is pointed out.